4.4 Article

Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

Related references

Note: Only part of the references are listed.
Editorial Material Oncology

Blogging during terminal care: Communication, color schemes, and creating a community

Leon A. Bach

JOURNAL OF CLINICAL ONCOLOGY (2008)

Article Immunology

Multiple costimulatory modalities enhance CTL avidity

JW Hodge et al.

JOURNAL OF IMMUNOLOGY (2005)